翰森制药再跌超5% 公司拟发行46.8亿港元的零息可换股债

Core Viewpoint - Hansoh Pharmaceutical (03692) has experienced a decline of over 5%, currently trading at HKD 38.48, with a transaction volume of HKD 69.45 million [1] Group 1: Financial Actions - The company announced a proposal to issue HKD 4.68 billion zero-coupon convertible bonds maturing in 2033, with a conversion price of HKD 57.39, representing a premium of approximately 42.62% over the previous trading day's closing price [1] - The expected net proceeds from the bond issuance are approximately HKD 4.64 billion [1] Group 2: Use of Proceeds - Approximately 65% of the proceeds will be allocated for drug research and development and licensing [1] - About 25% will be used for the construction of new research and development centers and production lines, as well as upgrading existing facilities [1] - The remaining 10% will be designated for working capital and other general corporate purposes [1]